Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2025 04:04 ET | Source: Research and Markets

Prostate-Specific Membrane Antigen (PSMA) Targeted Therapy Pipeline Review 2025 Tracks Drug Candidates for Prostate Cancer

Dublin, April 23, 2025 (GLOBE NEWSWIRE) -- The "PSMA - Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This report provides information on approved...
March 28, 2025 08:30 ET | Source: Ocean Biomedical, Inc.

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative treatments for cancer, infectious diseases,...
March 24, 2025 06:08 ET | Source: Research and Markets

Bispecific Antibody Drug Conjugates (BsADCs) Market Outlook 2024-2029: Additional Candidates Undergo Clinical Studies and Become Commercially Available

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Drug Conjugates Research Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Bispecific antibody...
March 12, 2025 08:48 ET | Source: Research and Markets

Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide

Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
March 04, 2025 05:28 ET | Source: Research and Markets

2025 Anti-CD38 Antibody Pipeline Insights for 10+ Companies and 12+ Pipeline Drugs, Including Felzartamab (I-MAB Biopharma), TAK-079 (Takeda), and ISB 1342 (Ichnos Sciences)

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Anti-CD38 Antibody - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
March 03, 2025 07:44 ET | Source: Research and Markets

PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies Business, Pipeline and Competitor Analysis Report 2025: Comprehensive Overview of R&D and Partnering Activities of Pharma and Technology Companies

Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies: A Business, Pipeline And Competitor Analysis From An Industry Perspective" report has been added...
February 18, 2025 10:29 ET | Source: Research and Markets

Bispecific Antibody Market Expands with Over 600 Clinical Trials – New Patent Analysis Report Released

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody & Cancer Patent Landscape Analysis" report has been added to ResearchAndMarkets.com's offering. The development of...
January 30, 2025 09:00 ET | Source: Orion Oyj

Orion ja Invenra solmivat tutkimuspalvelu- ja kaupallisen lisenssisopimuksen syöpähoitoihin tarkoitettujen innovatiivisten bispesifisten vasta-aineiden kehittämiseksi

ORION OYJ LEHDISTÖTIEDOTE 30.1.2025 KLO 16.00 Orion ja Invenra solmivat tutkimuspalvelu- ja kaupallisen lisenssisopimuksen syöpähoitoihin tarkoitettujen innovatiivisten...
January 30, 2025 09:00 ET | Source: Orion Oyj

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific...
December 13, 2024 09:11 ET | Source: Research and Markets

Blood Brain Barrier Technologies Market Outlook to 2028 & 2033

Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Blood Brain Barrier Technologies Market 2024" report has been added to ResearchAndMarkets.com's offering.The blood brain barrier technologies market...

Next Page keyboard_arrow_right